Liminatus pharma, inc. warrantsLIMNW.US Overview

US StockHealthcare

(No presentation for LIMNW)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock SentimentalTradingView Chart

LIMNW Overall Performance

LIMNW AI Analysis & Strategy

LIMNW Recent Performance

76.23%

Liminatus pharma, inc. warrants

0.81%

Avg of Sector

-1.14%

S&P500

LIMNW PowerScanner

LIMNW Key Information

LIMNW Valuation Metrics

LIMNW Earnings Table

LIMNW Profile

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.